Skip to main content

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

  • The original article was published in Alzheimer's Research & Therapy 2020 12:169

Correction to: Alz Res Ther (2020) 12:169

https://doi.org/10.1186/s13195-020-00738-8

Following publication of the original article [1], the authors noticed that the published figures have errors which was occurred during processing of the figures in production team.

  1. 1)

    fonts are shifted (Figure 1)

  2. 2)

    colors are not displayed (Figure 2, open circles should be colored)

  3. 3)

    labelling is incorrect (Figure 4, "Afl" should be "Aß", Supplementary Figures "D Absorbance" should be "Δ absorbance" (Δ = delta))

The correct Figures 1, 2 and 4 are shown below. The original article [1] has been updated.

figure1

Fig. 1

figure2

Fig. 2

figure3

Fig. 4

Reference

  1. 1.

    Stockmann J, Verberk IMW, Timmesfeld N, et al. Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline. Alz Res Ther. 2020;12:169 https://doi.org/10.1186/s13195-020-00738-8.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Klaus Gerwert.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stockmann, J., Verberk, I.M.W., Timmesfeld, N. et al. Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline. Alz Res Therapy 13, 25 (2021). https://doi.org/10.1186/s13195-021-00770-2

Download citation